Contents
On this page
- Clinical psychology and psychopathology in outline
- What this page is for
- The classification is a historical object, and saying so costs one line
- Describing a category without reifying it
- Report the criteria, the version and the instrument, every time
- Instrument choice is a measurement claim
- Writing about causes when the mechanisms are unsettled
- Prevalence and burden claims depend on the grouping
- Writing up treatment evidence
- Take-home message
- How to apply this to your study
- Common questions
Academy · Research Writing · Writing up psychopathology
Writing about psychopathology without reifying the diagnosis
Clinical psychology writing fails most often at one specific point: the sentence where a diagnostic label stops being a description of how participants were classified and starts behaving like a thing that exists and causes behaviour. The fix is mechanical — name the classification system and version, report the criteria and the instrument, and keep causal language proportionate to the design — but it has to be applied throughout, not patched in the discussion.
Psychiatric classification is a working tool with a contested history, and writing as though it were settled is the quickest way to lose a knowledgeable reviewer. Kawa and Giordano, in Philosophy, Ethics, and Humanities in Medicine, traced roughly sixty years of revision to the Diagnostic and Statistical Manual from its mid-twentieth-century inception, writing while the fifth edition was still in field trials ahead of its 2013 release. Their point is not that the manual is wrong but that its categories are historical products of a revision process. Your paper has to be written in a way that survives that fact.
Clinical psychology at a glance
- The subject
- The history, classification, causes and treatment of psychological disorders
- Classification
- Categorical manuals revised over about sixty years, with dimensional alternatives such as HiTOP9,28
- Causes
- Usually framed biopsychosocially; specific mechanisms remain largely unsettled30
- Treatment evidence
- Network meta-analyses of hundreds of randomised trials, mostly in adult depression31,32
- This page’s focus
- How to write about psychopathology so that claims match the classification and the design
- Reading time
- About 16 minutes, with 4 figures and 5 tables
What you will learn
- How to state a diagnostic classification so that a reader knows exactly how participants were assigned
- The difference between describing a category and reifying it, at sentence level
- Why the classification system’s own history is a limitation you can state in one line rather than an argument you have to win
- How to write about causes when the mechanisms are unsettled, without either overclaiming or saying nothing
- Why instrument choice is a measurement claim, and how to appraise one against the COSMIN structure
- How prevalence and burden figures depend on which conditions a grouping includes, and how to cite them honestly
What to unlearn
- “Saying DSM-5 is enough to specify the diagnosis.” It is not. The reader needs the edition, whether criteria were applied by structured interview, semi-structured interview, clinician judgement or self-report cut-off, who applied them, and what the agreement was.
- “Diagnostic categories are stable, so historical caveats are padding.” Kawa and Giordano document around six decades of revision across editions of the DSM. A category that changed in the last revision may change again, and if your conclusion depends on the boundary, that is a real limitation.
- “A validated screening instrument gives a diagnosis.” It gives a score above a threshold. Writing “participants with depression” where you mean “participants scoring above the cut-off on [instrument]” converts a measurement into an entity, and inflates every subsequent claim.
- “Group differences in a correlate explain the disorder.” A cross-sectional difference between a diagnosed group and controls is consistent with cause, consequence, confounding, medication, selection into care, or the diagnostic process itself. Say which of these your design excludes — usually none.
- “Published burden figures are interchangeable.” They depend on which conditions the grouping contains. The GBD 2021 analysis of disorders affecting the nervous system covers 37 conditions and is not a count of mental disorders; citing it as one is a category error a reviewer will catch.
Clinical psychology and psychopathology in outline
Clinical psychology is the branch of psychology concerned with understanding, assessing and treating psychological disorders; psychopathology is the study of the disorders themselves. An overview of the subject reduces to four questions that the peer-reviewed literature answers with very different degrees of confidence: how the current categories came about, how disorders should be classified, what causes them, and which treatments work. Figure 1 sets these out and Table 1 pairs each with a representative source.
History. Kawa and Giordano trace the Diagnostic and Statistical Manual through roughly sixty years of revision from its mid-twentieth-century inception to the field trials for the fifth edition, released in 2013, and argue that its categories are historical products of that process9.
Classification. Kotov and colleagues, writing in the Journal of Abnormal Psychology, argue that the reliability and validity of traditional taxonomies are limited by arbitrary boundaries between psychopathology and normality, unclear boundaries between disorders, frequent co-occurrence, heterogeneity within disorders and diagnostic instability. Their Hierarchical Taxonomy of Psychopathology (HiTOP) builds syndromes from the observed covariation of symptoms, combines co-occurring syndromes into spectra and characterises both dimensionally. The authors describe it as a work in progress, with several domains ready for clinical and research use28.
Causes. Engel’s 1977 paper in Science argued that the dominant biomedical model left no room for the social, psychological and behavioural dimensions of illness, and proposed a biopsychosocial model as a blueprint for research, a framework for teaching and a design for action in health care30. It is a framework for organising causal questions rather than a tested mechanism, a distinction this page returns to below.
Treatment and burden. For adult depression, a network meta-analysis of 331 randomised trials with 34,285 patients found every main psychotherapy more efficacious than care as usual and waiting list, with few differences between them31. The GBD 2019 Mental Disorders Collaborators estimated that mental disorders accounted for 125.3 million disability-adjusted life-years in 2019, 4.9% of the global total29.
Table 1. The questions of clinical psychology and a representative peer-reviewed source for each
| Question | Source | What it reports | Limit for a writer |
|---|---|---|---|
| History | Kawa and Giordano 2012, Philosophy, Ethics, and Humanities in Medicine9 | About sixty years of DSM revision; categories as products of a revision process | A conceptual history, not an empirical test of any category |
| Classification | Kotov et al. 2017, Journal of Abnormal Psychology28 | Boundary, comorbidity, heterogeneity and instability problems; HiTOP as a dimensional alternative | Described by its authors as a work in progress |
| Causes | Engel 1977, Science30 | Proposes a biopsychosocial model in place of a purely biomedical one | A framework, not evidence for any particular pathway |
| Treatment | Cuijpers et al. 2021, World Psychiatry31 | 331 trials, 34,285 patients: main psychotherapies for adult depression efficacious, with few differences between them | Adult depression only; response defined as a 50% reduction in symptoms |
| Burden | GBD 2019 Mental Disorders Collaborators 2022, Lancet Psychiatry29 | 125.3 million DALYs in 2019, 4.9% of global DALYs, across 12 mental disorders | Years of life lost estimated only for anorexia and bulimia nervosa |
Why the rest of this page is about writing
Because the categories are revisable, the causal frameworks are broad and the treatment evidence is condition-specific, the point at which most psychopathology manuscripts fail is not the clinical overview but the reporting of how a single study classified, measured and interpreted its participants, so the remainder of this article concentrates there.
What this page is for
Beyond the outline above, this is a writing page, not a clinical one. It does not tell you what psychopathology is, which classification to prefer, or how to treat anything. It addresses the narrower problem of how to report work on psychological disorders so that the claims in the paper match the evidence in the study — which is where most manuscripts in this area are weakest, and which is the part a reviewer can check without knowing your clinical speciality.
The area has a specific hazard that most of medicine does not. In much of clinical research the thing being studied can be measured independently of the classification used to describe it: a tumour exists whether or not the staging system changes. In psychopathology the classification often is the measurement, so a change to the criteria changes the population, the prevalence and sometimes the direction of a finding. That is not a reason to avoid the subject. It is a reason to write with the classification visible rather than assumed.
If your submission is to a psychology journal rather than a general medical one, the review conventions differ as well; our page on theoretical approaches and peer-review policies for psychology manuscripts covers that separately.
The classification is a historical object, and saying so costs one line
Kawa and Giordano, writing in Philosophy, Ethics, and Humanities in Medicine, set out a brief historicity of the Diagnostic and Statistical Manual covering roughly sixty years of revision from the manual’s mid-twentieth-century inception, with the fifth edition then in field trials for release in 2013. They examine the implications for psychiatric canon and practice across three issues 9. The analysis is useful to a writer for one reason: it establishes that the categories you are using were produced by a process, with decisions, disagreements and revisions, rather than discovered 9.
The practical consequence is small and specific. You do not need to argue the philosophy of psychiatric nosology in your introduction — that is a different paper, and in a clinical journal it will read as padding. What you need is for your writing not to depend on the categories being natural kinds. In most papers that amounts to: name the system and edition in the methods; avoid phrasing that treats the category as the cause of the symptoms; and if your finding sits near a diagnostic boundary that has moved between editions, say so in the limitations.
What this page’s sources do not cover is the comparative literature on dimensional alternatives to categorical diagnosis. Those frameworks exist and are actively debated, and we are not citing them here because the citable material behind this page does not extend to them. If your argument turns on that debate, it needs its own sources rather than a gesture.
Describing a category without reifying it
Reification is a grammatical habit more than a theoretical position, which is why it survives careful authors. It happens when the diagnostic label becomes the subject of a verb it cannot perform. Depression causes rumination. The disorder impairs working memory. Anxiety drives avoidance. Each of these says that a classification — a decision rule applied to a set of reported experiences — is acting on a person. At best it is shorthand; at worst it smuggles in a causal model the study did not test.
The alternative is not to write in permanent circumlocution. It is to be accurate about what you observed. If participants meeting criteria for a disorder scored lower on a working-memory task than controls, write that. If a symptom measure predicted a behavioural measure, write that, with the design named. The sentence gets slightly longer and loses nothing a reader needed.
Three habits do most of the work. First, keep the classification in the subject position only where the classification is genuinely what you studied — a paper about diagnostic agreement can legitimately make the category the subject. Second, prefer “participants meeting criteria for X” to “patients with X” in the results, and use person-first phrasing consistently in the discussion. Third, read every causal verb in the paper — causes, leads to, drives, produces, results in, impairs — and check against the design whether you are entitled to it. In a cross-sectional study the answer is no, every time.
The same finding, written as a reified entity and as an observation
| Reified | What it implicitly claims | Accurate version |
|---|---|---|
| “Depression impairs working memory.” | That a diagnostic category is an agent acting on cognition, and that the direction is established | “Participants meeting criteria for major depressive disorder scored lower on the working-memory task than controls.” |
| “Anxiety drives avoidance behaviour.” | A tested causal pathway | “Higher scores on the anxiety measure were associated with more frequent avoidance, measured concurrently.” |
| “Patients with PTSD show reduced hippocampal volume.” | That the difference is a feature of the disorder rather than of treatment, comorbidity or selection into care | “In this sample, participants meeting criteria for PTSD had smaller mean hippocampal volume than controls; the groups also differed in medication exposure and comorbidity.” |
| “The disorder emerged in adolescence.” | That the condition has an onset independent of when it was classified | “Criteria were first met at a mean age of 14.8 years, based on retrospective report.” |
| “Participants with depression (n = 52).” | A diagnosis, where usually only a threshold score exists | “Participants scoring at or above the published cut-off on [instrument] (n = 52), hereafter probable depression.” |
Illustrative pairs written for this page; the figures in them are examples, not findings. The underlying argument that diagnostic categories are products of a revision process rather than discovered kinds follows Kawa and Giordano in Philosophy, Ethics, and Humanities in Medicine.
Report the criteria, the version and the instrument, every time
The single most common methodological gap in psychopathology manuscripts is a methods section that names a disorder without specifying how anyone was assigned to it. “Fifty-two patients with generalised anxiety disorder were recruited” tells a reader nothing they can evaluate. The questions a reviewer will ask, in order: which classification system and which edition; applied by what procedure; by whom, with what training; with what inter-rater agreement; and if an instrument was used, which version, in which language, with which threshold 9.
Thresholds deserve particular attention because they are where a measurement turns into a diagnosis without anyone noticing. A screening instrument with a published cut-off identifies people likely to meet criteria; it does not establish that they do 11. If your classification rests on a cut-off, say so plainly in the methods and carry the qualification into the abstract, because the abstract is where the overstatement usually appears. “Participants with probable depression, defined as a score of at least X on [instrument]” is both honest and short.
Comorbidity is the other routine omission. Psychiatric categories co-occur heavily, so a sample defined by one diagnosis usually contains people who also meet criteria for others. If you did not assess comorbidity, that is a limitation; if you did, report it, because a reader cannot otherwise tell whether your effect belongs to the category you named. The same applies to current medication, which in treated samples is a near-universal confounder for any biological or cognitive correlate.
A sample description, before and after it can be evaluated
Reifies the label
We recruited 52 patients with major depressive disorder and 50 healthy controls. Depression was diagnosed according to DSM-5 criteria. All participants completed a battery of cognitive tasks. Patients with depression performed significantly worse than controls on tests of executive function, indicating that depression impairs executive functioning.
Who applied the criteria, and how? “Diagnosed according to DSM-5 criteria” covers everything from a structured interview by a trained rater to a case-note code, and these are not equivalent.
What was the agreement? With no reliability figure, the classification that defines the entire study is unquantified.
What else were they experiencing, and what were they taking? Comorbidity and medication are unreported, so the group difference cannot be attributed to the named category.
Were the controls screened? “Healthy controls” is an assertion, not a procedure.
“Indicating that depression impairs executive functioning” converts a cross-sectional group difference into a causal claim, with the diagnostic label as the agent.
Reports the classification
We recruited 52 adults meeting DSM-5 criteria for a current major depressive episode and 50 comparison participants with no lifetime psychiatric diagnosis. Criteria were applied using a semi-structured diagnostic interview administered by two clinical psychologists who had completed the instrument’s training programme; 20% of interviews were double-rated, with agreement reported in the supplement. Comorbid anxiety disorders were present in 23 of the 52, and 34 were taking antidepressant medication at assessment. Participants completed three executive-function tasks, pre-specified as the primary cognitive outcome. The group meeting criteria scored lower than the comparison group on all three. Because the design is cross-sectional and the groups differed in medication exposure and comorbidity, these data are consistent with executive difficulty as a feature, a consequence or a correlate of the episode, and do not establish direction.
The classification procedure, the raters, their training and the double-rating are all stated, so the defining variable of the study can be judged.
“Meeting criteria for” keeps the category as a description of how people were assigned rather than as an entity.
Comorbidity and medication are reported as numbers, so a reader can see the competing explanations rather than having to raise them.
The comparison group is defined by a screening procedure rather than by the word “healthy”.
The cognitive outcome is pre-specified, which removes the suspicion of selection among several available measures.
The closing sentence states the strongest supportable claim and the alternatives in the same breath, in the results rather than three pages later.
The second version reports a weaker conclusion from the same data, and is the more publishable of the two. Every addition answers a question a reviewer in this field asks automatically — who classified, with what agreement, what else was going on, and what the design can support. Note that the honest version also reads as more confident, because it is not asking to be trusted on any of these points.
Instrument choice is a measurement claim
Almost everything in this field is measured with a questionnaire or a rated interview, which means instrument quality is not a technical appendix — it is the evidential basis of the result. The vocabulary for stating that quality precisely is the COSMIN taxonomy, which Mokkink and colleagues established in the Journal of Clinical Epidemiology through four Delphi rounds with 43 participating experts at a 67% consensus threshold, organising instrument quality into 3 domains, 7 measurement properties and 4 aspects 13. Using those terms lets you write “structural validity has not been examined in this population” instead of the uninformative “the scale is valid and reliable”.
Two consequences for a psychopathology paper. The first is that “validated” is not a property an instrument carries permanently; it holds for a population and a purpose 13,25. A scale validated in community samples of adults may have no structural validity evidence in adolescents, in an inpatient sample, or in the language you administered. Say which population the validation evidence comes from.
The second is that scarcity is real and worth checking. Churruca and colleagues, reviewing patient-reported outcome measures in Health Expectations, screened 6,453 citations and identified 315 instruments, of which only 39 were generic — so cross-condition comparability is the scarce commodity 4. If your study compares across diagnostic groups, a condition-specific measure will not support the comparison, however well validated it is within each group 4. Our page on PRO instrument types covers the choice, and developing and evaluating an instrument covers what to do when nothing fits.
Writing about causes when the mechanisms are unsettled
The causal literature in psychopathology is genuinely unsettled, and the honest way to write about it is to be specific about what kind of claim you are making. Three levels are worth distinguishing explicitly in your own text.
Association. Two things co-occur in your sample, with a stated effect size and interval. Almost all cross-sectional work lives here, and it is a respectable place to live. The phrasing is “was associated with”, and the limitation is that direction and confounding are unresolved.
Temporal order. One thing preceded the other in a design capable of showing it — a prospective cohort with the exposure measured before the outcome, and with the baseline level of the outcome adjusted for. This supports “predicted” and licenses a cautious discussion of direction, with residual confounding still open.
Mechanism. A pathway was manipulated or specified and tested. Very little work in this field reaches here, and a mechanistic discussion appended to an associational result is the most common form of overclaiming in psychopathology manuscripts.
The useful discipline is to write the strongest claim your design supports, and then write the sentence that says what it does not support — in the same paragraph, not in a limitations list the reader reaches three pages later. Where a biological correlate is involved, the additional problem is that the correlate may be a consequence of the disorder, of its treatment, or of the circumstances of being diagnosed; our page on biological factors and brain change across the lifespan deals with that pattern in more detail.
Overclaims the design
“Childhood adversity causes adult depression by dysregulating the stress response.”
A mechanistic verb and pathway attached to a cross-sectional association with retrospectively reported exposure.
Matches the design
“Retrospectively reported childhood adversity was associated with higher depressive symptom scores; the cross-sectional design cannot establish temporal order or mechanism.”
The strongest supportable claim, followed in the same sentence by what the design cannot show.
Illustrative sentences written for this page; they do not report findings from any study.
Prevalence and burden claims depend on the grouping
Introductions in this field almost always open with a burden figure, and it is worth understanding what such a figure is before you borrow one. The GBD 2021 Nervous System Disorders Collaborators, in The Lancet Neurology, reported that in 2021 disorders affecting the nervous system were the leading grouped cause of disability-adjusted life-years, accounting for 443 million DALYs (95% uncertainty interval 378–521) and affecting 3.40 billion people, or 43.1% of the world’s population, across 37 conditions in 204 countries and territories 26.
That is a striking number and it is not a count of mental disorders. It is a count for a grouping of 37 conditions affecting the nervous system, and what that grouping contains is a classification decision made by the analysts 26. Cited as evidence of psychiatric burden it is simply wrong, and a reviewer in the field will recognise it. The teaching point generalises: every prevalence or burden figure is a figure for a defined set of conditions, in a defined population, estimated by a stated method, and the three parts travel together or the figure means nothing.
So when you cite one: name the source and the year, state the grouping it covers, give the uncertainty interval rather than the point estimate alone, and make sure the grouping is the one your paper is about. If the figure you want does not exist for your condition, the right move is to say that the burden of this condition has not been estimated separately in the global estimates, which is informative, rather than to substitute a neighbouring figure, which is not.
These figures are for disorders affecting the nervous system as a grouping, not for mental disorders, which GBD classifies separately. Source: GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology.
The mental-disorder figures are a separate set. The GBD 2019 Mental Disorders Collaborators, in The Lancet Psychiatry, covered 12 mental disorders in 204 countries and territories and reported that DALYs due to mental disorders rose from 80.8 million (95% UI 59.5–105.9) in 1990 to 125.3 million (93.0–163.2) in 2019, while age-standardised DALY rates stayed largely constant. Because only anorexia nervosa and bulimia nervosa were identified as underlying causes of death, the authors note that their years-of-life-lost estimates do not reflect premature mortality among people with mental disorders29. Figure 4 and Table 2 show why the two groupings cannot be swapped.
Table 2. Two global burden groupings that are often confused
| Feature | Disorders affecting the nervous system (GBD 2021) | Mental disorders (GBD 2019) |
|---|---|---|
| Conditions | 37 conditions affecting the nervous system26 | 12 mental disorders, including depressive, anxiety, bipolar, eating and conduct disorders, schizophrenia, autism spectrum disorders and ADHD29 |
| Headline burden | 443 million DALYs in 2021 (95% UI 378–521 million) | 125.3 million DALYs in 2019 (95% UI 93.0–163.2 million) |
| Coverage | 204 countries and territories | 204 countries and territories, 23 age groups, 1990–2019 |
| Appropriate citation | Burden of neurological and nervous-system conditions as a group | Burden of mental disorders, stating which disorders were included |
Figures as reported in the abstracts of the two GBD analyses.
Writing up treatment evidence
Treatment claims attract the closest scrutiny in this area, for good reason: the outcomes are self-reported, blinding of psychological interventions is usually impossible, and expectancy effects are large. None of that invalidates the work, but it determines how the result can be worded.
Four things carry most of the weight, and each is a sentence a reviewer looks for.
Checklist for reporting a psychological treatment trial
- State the primary outcome and its timepoint as pre-specified, with the registration if there is one; where several plausible outcome measures exist for every condition, an unregistered primary outcome invites the suspicion that it was chosen after the analysis1.
- State who was blind to what, including the outcome assessor; if nobody was, say so rather than omitting the sentence.
- Report the comparator precisely, because “treatment as usual” describes very different things in different services and an effect size cannot be interpreted without it.
- Report attrition by arm and state how missing data were handled, since differential dropout is common and consequential in psychological trials.
The corresponding reporting guideline for your design will list these items as requirements, which makes it a drafting tool rather than a submission formality. Working through it before writing the methods is also the cheapest way to avoid the structural objections that account for most manuscript rejections 6.
The best-known syntheses in the field show what this looks like at scale. Table 3 summarises three network meta-analyses of adult depression; each defines its outcome explicitly, names its comparators and reports intervals, which is the standard a single trial report is read against.
Table 3. What three network meta-analyses report about treating adult depression
| Study | Evidence base | Comparison | Main finding |
|---|---|---|---|
| Cuijpers et al. 2020, World Psychiatry32 | 101 studies, 11,910 patients | Psychotherapy, pharmacotherapy and their combination; response = 50% improvement | Combination more effective than psychotherapy alone (RR 1.27; 95% CI 1.14–1.39) and pharmacotherapy alone (RR 1.25; 1.14–1.37); no difference between psychotherapy and pharmacotherapy (RR 0.99; 0.92–1.08) |
| Cuijpers et al. 2021, World Psychiatry31 | 331 randomised trials, 34,285 patients | Eight psychotherapy types against each other and against care as usual, waiting list and pill placebo | All more efficacious than care as usual and waiting list; standardised mean differences against care as usual from −0.81 (life-review therapy) to −0.32 (non-directive supportive counselling) |
| Furukawa et al. 2021, World Psychiatry33 | 81 randomised trials, 13,722 participants | Initial treatment and sustained response through a maintenance phase (mean 42.2 weeks) | Psychotherapy and combination kept patients well more often than pharmacotherapy; against a 29% sustained response on standard treatment, risk differences of 12 to 16 percentage points |
Figures as reported in each study’s abstract. Results apply to adult depression and should not be generalised to other disorders without separate evidence.
Take-home message
Take-home message
Write with the classification visible. Name the system and edition, state how criteria were applied and by whom, report agreement, comorbidity and medication, and keep the diagnostic label out of the subject position of causal verbs. Kawa and Giordano’s account of roughly sixty years of DSM revision is not an argument you need to have in your introduction; it is the reason your paper should not depend on the categories being natural kinds. Match causal language to the design — association, temporal order, mechanism — and when you cite a burden figure, cite the grouping and the uncertainty interval with it. The GBD 2021 figure of 443 million DALYs is for 37 nervous-system conditions, not for mental disorders, and borrowing it as one is a mistake a reviewer will find.
How to apply this to your study
How to apply this to your own study
- Search your manuscript for the disorder name followed by a verb. Every instance where the category is the subject of causes, leads to, drives, impairs or produces needs rewriting or justifying.
- Write one methods sentence that fully specifies classification: system, edition, procedure, rater, training, and agreement. If you cannot, you have found a limitation to state.
- Replace every threshold with its threshold. If a cut-off defined the group, the word in the abstract is “probable”, and the instrument and score belong in the methods.
- Report comorbidity and current medication by group, or state explicitly that they were not assessed.
- Define the comparison group by procedure, not by the adjective “healthy”.
- Name the validation population for every instrument you used, and say in COSMIN terms which properties are unexamined in a sample like yours.
- Check each burden or prevalence figure against its grouping before it enters your introduction, and quote the uncertainty interval alongside the point estimate.
- Put the counter-explanation in the same paragraph as the finding, not only in the limitations — medication, comorbidity, direction of effect, selection into care.
Common questions
Keep the category as a description of how participants were assigned rather than as an agent. In practice that means preferring “participants meeting criteria for X” to “patients with X” in the methods and results, and never letting the disorder name be the subject of a causal verb — no “depression impairs”, no “anxiety drives”. Report what you observed: which group scored lower on which measure, with what design. The sentence lengthens slightly and loses nothing a reader needed. This is a grammatical discipline rather than a theoretical commitment, and it is why Kawa and Giordano’s point about the DSM being a revised historical product can be handled in one limitation line rather than an argument.
No. That phrase is compatible with a structured interview by a trained clinician, an unstructured clinical impression, and a diagnostic code copied from a medical record, which are not equivalent sources of a study’s defining variable. A reviewer will want the edition, the procedure, who applied it and with what training, and the inter-rater agreement if more than one person was involved. If classification came from case notes or a registry, say so and treat it as a limitation rather than describing it as diagnosis. Kawa and Giordano’s historicity of the manual also makes the edition load-bearing: criteria change between revisions, and a sample defined under one edition is not identical to one defined under another.
Not without qualification. A screening instrument identifies people likely to meet criteria; it does not establish that they do, and its published cut-off was set for a particular population and purpose. The accurate formulation names the measurement: “participants scoring at or above [score] on [instrument], hereafter probable depression”. Carry the qualifier into the abstract, because that is where it usually gets dropped and where the inflated claim then circulates. This is also where instrument appraisal matters: the COSMIN structure lets you say which properties are established in a population like yours, rather than describing the scale as valid and reliable and leaving the reader to assume the rest.
Name the level of claim your design supports and then state what it excludes, in the same paragraph. Cross-sectional work supports association: two things co-occur, with an effect size and interval, and direction and confounding stay open. A prospective design with the exposure measured before the outcome and the baseline outcome adjusted for supports temporal order and the word “predicted”. Mechanism requires a pathway to have been manipulated or specified and tested, and very little work in psychopathology reaches it. The common failure is a mechanistic discussion attached to an associational result. Writing the weaker claim explicitly is not hedging; it is the difference between a finding a reviewer can accept and one they have to challenge.
Only if the figure is actually about your condition. Burden estimates are produced for defined groupings, and the grouping is a classification decision, not a natural boundary. The GBD 2021 Nervous System Disorders Collaborators reported 443 million DALYs (95% UI 378–521) in 2021 across 37 conditions in 204 countries, affecting 3.40 billion people or 43.1% of the world’s population — and that is for disorders affecting the nervous system, which GBD treats separately from mental disorders. Cited as psychiatric burden it is a category error. When you use any such figure, give the source, the year, the grouping and the uncertainty interval. If no separate estimate exists for your condition, say that, which is itself informative.
Yes, or state that you did not assess them. Psychiatric categories co-occur heavily, and most treated samples are on medication, so both are competing explanations for any group difference you report — cognitive, biological or behavioural. A reader who cannot see them cannot tell whether your effect belongs to the category you named. Reporting them costs two sentences in the sample description and removes an objection that would otherwise be raised as a criticism. Where they were not assessed, say so plainly in the limitations and scope the interpretation accordingly, rather than leaving the omission for a reviewer to discover.
With one line in the methods and, if relevant, one in the limitations — not with a philosophical excursion. Kawa and Giordano, in Philosophy, Ethics, and Humanities in Medicine, trace roughly sixty years of DSM revision and its implications, which is enough to establish that the categories were produced rather than discovered. For a clinical paper, what follows is practical: name the edition you used, do not let your conclusion rest on the category being a natural kind, and if your finding sits near a boundary that moved between editions, say so. Note that the comparative literature on dimensional alternatives is beyond the sources behind this page; if your argument depends on it, cite that literature directly.
Four things, and all four are often missing. A pre-specified primary outcome with its timepoint, ideally registered, because many plausible outcome measures exist for any condition and an unregistered primary invites suspicion of selection. Who was blind to what, including the outcome assessor — blinding participants to a psychological intervention is usually impossible, so the honest sentence says so rather than being omitted. A precise description of the comparator, since “treatment as usual” means different things in different services and an effect size is uninterpretable without it. And attrition by arm with the missing-data approach stated, because differential dropout is common and changes what the analysis means.
References and sources
- International Committee of Medical Journal Editors (ICMJE). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. 2026. read 9 October 2026. icmje.org
- US Department of Health and Human Services, Food and Drug Administration (CDER, CBER, CDRH). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. 2009. read 9 October 2026. hhs.gov
- Bethlehem RAI, Seidlitz J, White SR, et al. Brain charts for the human lifespan. Nature. 2022;604(7906). doi:10.1038/s41586-022-04554-y read 9 October 2026. doi.org/10.1038/s41586-022-04554-y
- Churruca K, Pomare C, Ellis LA, Long JC, Henderson SB, Murphy LED, Leahy CJ, Braithwaite J. Patient-reported outcome measures (PROMs): a review of generic and condition-specific measures and a discussion of trends and issues. Health Expectations. 2021;24(4):1015-1024. doi:10.1111/hex.13254 read 9 October 2026. doi.org/10.1111/hex.13254
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021:n71. doi:10.1136/bmj.n71 read 9 October 2026. doi.org/10.1136/bmj.n71
- Jawaid SA, Jawaid M. Common reasons for not accepting manuscripts for further processing after editor's triage and initial screening. Pakistan Journal of Medical Sciences. 2019;35(1):1-3. doi:10.12669/pjms.35.1.28 read 9 October 2026. doi.org/10.12669/pjms.35.1.28
- Terwee CB, Prinsen CAC, Chiarotto A, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Quality of Life Research. 2018;27:1159-1170. doi:10.1007/s11136-018-1829-0 read 9 October 2026. doi.org/10.1007/s11136-018-1829-0
- Fujita MSL, Agustin-Lacruz MdC, Terra AL. Journals' guidelines about title, abstract and keywords: an overview of Information Science and Communication Science areas. European Science Editing. 2018;44(4):76-79. read 9 October 2026. europeanscienceediting.org.uk
- Kawa S, Giordano J. A brief historicity of the Diagnostic and Statistical Manual of Mental Disorders: issues and implications for the future of psychiatric canon and practice. Philosophy, Ethics, and Humanities in Medicine. 2012;7:2. doi:10.1186/1747-5341-7-2 read 9 October 2026. doi.org/10.1186/1747-5341-7-2
- Olshansky E, Lakes KD, Vaughan J, et al. Enhancing the construct and content validity of rating scales for clinical research. The International Journal of Education and Psychological Assessment. 2012;10(1):36-50. read 9 October 2026. link.springer.com
- de Vet HCW, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine. Cambridge University Press. 2011. read 9 October 2026. link.springer.com
- Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Quality of Life Research. 2010;19(4):539-549. read 9 October 2026. link.springer.com
- Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. Journal of Clinical Epidemiology. 2010;63(7):737-745. doi:10.1016/j.jclinepi.2010.02.006 read 9 October 2026. doi.org/10.1016/j.jclinepi.2010.02.006
- Sijtsma K. On the use, the misuse, and the very limited usefulness of Cronbach's alpha. Psychometrika. 2009;74(1):107-120. read 9 October 2026. link.springer.com
- Kuper A, Reeves S, Levinson W. An introduction to reading and appraising qualitative research. BMJ. 2008;337:a288. read 9 October 2026. link.springer.com
- Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. Oxford University Press. 2008. read 9 October 2026. link.springer.com
- Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology. 2007;60(1):34-42. read 9 October 2026. link.springer.com
- von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806-808. doi:10.1136/bmj.39335.541782.AD read 9 October 2026. doi.org/10.1136/bmj.39335.541782.AD
- Vogt DS, King DW, King LA. Focus groups in psychological assessment: enhancing content validity by consulting members of the target population. Psychological Assessment. 2004;16(3):231-243. read 9 October 2026. link.springer.com
- Sollaci LB, Pereira MG. The Introduction, Methods, Results, and Discussion (IMRAD) structure: a fifty-year survey. Journal of the Medical Library Association. 2004;92(3):364-371. read 9 October 2026. genreacrossborders.uwaterloo.ca
- Aaronson N, Alonso J, Burnam A, et al. Assessing health status and quality-of-life instruments: attributes and review criteria. Quality of Life Research. 2002;11(3):193-205. read 9 October 2026. link.springer.com
- Lohr KN, Aaronson NK, Alonso J, et al. Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clinical Therapeutics. 1996;18(5):979-992. read 9 October 2026. link.springer.com
- Cortina JM. What is coefficient alpha? An examination of theory and applications. Journal of Applied Psychology. 1993;78:98-104. read 9 October 2026. link.springer.com
- Huth EJ. Structured abstracts for papers reporting clinical trials. Annals of Internal Medicine. 1987;106(4):626-627. read 9 October 2026. stat.cmu.edu
- Messick S. Test validity and the ethics of assessment. American Psychologist. 1980;35:1012-1027. read 9 October 2026. link.springer.com
- GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology. 23(4):344-381. read 9 October 2026. ro.uow.edu.au
- Fernandez E, Garcia AM, Seres E, Bosch F. Students' satisfaction and perceived impact on knowledge, attitudes and skills after a 2-day course in scientific writing: a prospective longitudinal study in Spain. BMJ Open. 8(1):e018657. read 9 October 2026. bmjopen.bmj.com
- Kotov R, Krueger RF, Watson D, et al. The Hierarchical Taxonomy of Psychopathology (HiTOP): a dimensional alternative to traditional nosologies. Journal of Abnormal Psychology. 2017;126(4):454-477. doi:10.1037/abn0000258 read 13 November 2026. doi.org/10.1037/abn0000258
- GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Psychiatry. 2022;9(2):137-150. doi:10.1016/S2215-0366(21)00395-3 read 13 November 2026. doi.org/10.1016/S2215-0366(21)00395-3
- Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196(4286):129-136. doi:10.1126/science.847460 read 13 November 2026. doi.org/10.1126/science.847460
- Cuijpers P, Quero S, Noma H, et al. Psychotherapies for depression: a network meta-analysis covering efficacy, acceptability and long-term outcomes of all main treatment types. World Psychiatry. 2021;20(2):283-293. doi:10.1002/wps.20860 read 13 November 2026. doi.org/10.1002/wps.20860
- Cuijpers P, Noma H, Karyotaki E, Vinkers CH, Cipriani A, Furukawa TA. A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry. 2020;19(1):92-107. doi:10.1002/wps.20701 read 13 November 2026. doi.org/10.1002/wps.20701
- Furukawa TA, Shinohara K, Sahker E, et al. Initial treatment choices to achieve sustained response in major depression: a systematic review and network meta-analysis. World Psychiatry. 2021;20(3):387-396. doi:10.1002/wps.20906 read 13 November 2026. doi.org/10.1002/wps.20906
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 9). Writing about psychopathology without reifying the diagnosis. Pubrica. https://pubrica.com/academy/medical-writing/clinical-psychology-psychopathology-by-systematically-examining-the-history-classification-causes-and-treatment-of-psychological-disorders/
Pubrica Academy. “Writing About Psychopathology Without Reifying the Diagnosis.” Pubrica, 9 Oct. 2026, pubrica.com/academy/medical-writing/clinical-psychology-psychopathology-by-systematically-examining-the-history-classification-causes-and-treatment-of-psychological-disorders/.
Pubrica Academy (2026) Writing about psychopathology without reifying the diagnosis. Pubrica. Available at: https://pubrica.com/academy/medical-writing/clinical-psychology-psychopathology-by-systematically-examining-the-history-classification-causes-and-treatment-of-psychological-disorders/ (Accessed: 15 October 2026).
Pubrica Academy. “Writing About Psychopathology Without Reifying the Diagnosis.” Pubrica. October 9, 2026. https://pubrica.com/academy/medical-writing/clinical-psychology-psychopathology-by-systematically-examining-the-history-classification-causes-and-treatment-of-psychological-disorders/
Pubrica Academy, ‘Writing about psychopathology without reifying the diagnosis’ (Pubrica, 9 October 2026) <https://pubrica.com/academy/medical-writing/clinical-psychology-psychopathology-by-systematically-examining-the-history-classification-causes-and-treatment-of-psychological-disorders/> accessed 15 October 2026.
Pubrica Academy. Writing about psychopathology without reifying the diagnosis. [Internet]. Pubrica; 2026 Oct 9 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/medical-writing/clinical-psychology-psychopathology-by-systematically-examining-the-history-classification-causes-and-treatment-of-psychological-disorders/
Pubrica Academy, “Writing about psychopathology without reifying the diagnosis,” Pubrica, Oct. 9, 2026. [Online]. Available: https://pubrica.com/academy/medical-writing/clinical-psychology-psychopathology-by-systematically-examining-the-history-classification-causes-and-treatment-of-psychological-disorders/
@misc{clinical_psychology_psychopathology_by_2026,
author = {{Pubrica Academy}},
title = {Writing about psychopathology without reifying the diagnosis},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/medical-writing/clinical-psychology-psychopathology-by-systematically-examining-the-history-classification-causes-and-treatment-of-psychological-disorders/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Psychopathology reporting check
Run this over a draft before it goes to a supervisor or a journal. It is written for papers where participants are grouped by a psychiatric classification, and most of it applies whether the outcome is clinical, cognitive or biological.
PSYCHOPATHOLOGY REPORTING CHECK
Manuscript: ______________________ Design: ______________________
1. CLASSIFICATION - the defining variable of the study
[ ] Classification system AND edition named: ______________________
[ ] Procedure named (structured interview / semi-structured interview /
clinician judgement / case-note code / self-report cut-off): ________
[ ] Instrument and version, if one was used: ______________________
[ ] Who applied it, and their training: ______________________
[ ] Inter-rater agreement reported, or stated as not assessed
[ ] If a cut-off defined the group, the word "probable" appears in the
abstract and the score appears in the methods
2. THE SAMPLE A READER CANNOT INTERPRET WITHOUT
[ ] Comorbidity assessed and reported by group, or declared unassessed
[ ] Current medication reported by group, or declared unassessed
[ ] Comparison group defined by a screening PROCEDURE, not by the word
"healthy"
[ ] Recruitment route stated (clinic / community / registry) - this is a
selection claim, not a logistics detail
[ ] Episode status stated (current / remitted / lifetime)
3. LANGUAGE - reification check
Search the manuscript for the disorder name. For every instance:
[ ] Is the label the SUBJECT of a causal verb (causes, leads to, drives,
produces, impairs, results in)? If yes, rewrite.
[ ] Is "patients with X" used where "participants meeting criteria for X"
is what you mean?
[ ] Does any sentence treat the category as having an onset, a course or
an effect independent of how it was classified?
4. MEASUREMENT
For each instrument used:
Name and version: ______________________ Language: ____________
Validation population: ______________________
Properties ESTABLISHED in a population like mine: ________________
Properties NOT established: ______________________
[ ] "Valid and reliable" does not appear anywhere in the manuscript
[ ] If comparing ACROSS diagnostic groups, the measure is generic rather
than condition-specific
5. CAUSAL LANGUAGE - match to design
My design supports (circle one):
ASSOCIATION / TEMPORAL ORDER / MECHANISM
[ ] Every claim in the abstract is at or below that level
[ ] Every claim in the discussion is at or below that level
[ ] The counter-explanations appear in the same paragraph as the finding:
medication ____ comorbidity ____ direction ____
selection into care ____ diagnostic process itself ____
6. EXTERNAL FIGURES
For every prevalence or burden figure cited:
Source and year: ______________________
Grouping it covers: ______________________
Is that grouping the one my paper is about? Y / N
Uncertainty interval quoted alongside the point estimate? Y / N
7. IF THIS IS A TREATMENT STUDY
[ ] Primary outcome and timepoint pre-specified; registration cited
[ ] Who was blind to what, stated - including "nobody was" if true
[ ] Comparator described specifically enough to interpret an effect size
[ ] Attrition by arm, with missing-data handling stated
[ ] Reporting guideline for this design worked through item by item:
guideline used: ______________________
8. ONE-LINE LIMITATIONS TO DRAFT NOW
Classification: ______________________________________________
Measurement: _________________________________________________
Design and causal reach: _____________________________________ Pubrica AcademyWritten and maintained by the subject matter experts of Pubrica who do this work. Articles are revised when the standard underneath them moves, and each one carries the date it was last checked.
How Pubrica helps
Pubrica’s medical writing team reads psychopathology manuscripts for the two failures that cost most at review: a classification described in a way no reader can evaluate, and causal language running ahead of the design. We rewrite the sample description so the assignment procedure is visible, check each instrument claim against what the validation evidence actually covers, and verify every borrowed prevalence or burden figure against the grouping it was estimated for.